330 related articles for article (PubMed ID: 30880589)
21. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
22. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population.
Yamamoto H; Hanafusa H; Ouchida M; Yano M; Suzuki H; Murakami M; Aoe M; Shimizu N; Nakachi K; Shimizu K
Carcinogenesis; 2005 Feb; 26(2):411-6. PubMed ID: 15550454
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC; Wang J
J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
[TBL] [Abstract][Full Text] [Related]
25. Variants of SMAD1 gene increase the risk of colorectal cancer in the Bangladeshi population.
Karmokar PF; Shabnaz S; Aziz MA; Asaduzzaman M; Shahriar M; Bhuiyan MA; Mosaddek ASM; Islam MS
Tumour Biol; 2020 Sep; 42(9):1010428320958955. PubMed ID: 32921281
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
27. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
[TBL] [Abstract][Full Text] [Related]
28. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
29. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
[TBL] [Abstract][Full Text] [Related]
30. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
31. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
32. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
[TBL] [Abstract][Full Text] [Related]
33. CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
[TBL] [Abstract][Full Text] [Related]
34. Association of CDH1 promoter polymorphism and the risk of non-syndromic orofacial clefts in a Chinese Han population.
Song Y; Zhang S
Arch Oral Biol; 2011 Jan; 56(1):68-72. PubMed ID: 20880515
[TBL] [Abstract][Full Text] [Related]
35. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
36. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
Li W; Xiao D; Wu H; Xu L
Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
[TBL] [Abstract][Full Text] [Related]
37. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
[TBL] [Abstract][Full Text] [Related]
38. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
39. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
[TBL] [Abstract][Full Text] [Related]
40. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
Grünhage F; Jungck M; Lamberti C; Berg C; Becker U; Schulte-Witte H; Plassmann D; Rahner N; Aretz S; Friedrichs N; Buettner R; Sauerbruch T; Lammert F
Int J Colorectal Dis; 2008 Feb; 23(2):147-54. PubMed ID: 17960397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
